SynthesisBMJ open2020

What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic review.

Sandra Miriam Kawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.